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Purpose: To investigate the inhibitory effect of Ras-related C3 botulinum toxin substrate 1-small interfering RNA (Rac1-
siRNA) on retinal neovascularization in a rat model.
Methods: Rac1-short hairpin RNA (shRNA) was synthesized, constructed, and transfected into HeLa cells. Reverse
transcription polymerase chain reaction was then conducted to test for Rac1 gene expression. Retinal vein obstruction was
performed in 25 Sprague-Dawley rats using the retinal photodynamic method. The vitrea bulbus of the eye in the shRNA
rats group was transfected with the Rac1-shRNA vector, the other eye in the blank control group was transfected with the
blank vector, and the interference control group was prepared by transfecting the Rac1-shRNA vector. Two weeks after
transfection, the neonatal vessels were tested using fluorescein isothiocyanate–dextran retinal angiography. The number
of endothelial cells beyond the internal limiting membrane was counted with hematoxylin and eosin staining.
Results: A large area of neovascularization and fluorescein isothiocyanate leakage was found in the positive control group.
However, a small area of neovascularization and a little fluorescence leakage were found in the shRNA group, whereas
the retinal vessels were normal in the negative control interference group. In the shRNA interference group, the mean
number of endothelial cells beyond the internal limiting membrane was significantly higher than that in the positive control
group or the interference negative control group (p<0.05).
Conclusions: Silencing Rac1 expression with RNA interference inhibits retinal neovascularization in rats.
Neovascularization plays important roles in embryonic
development and tissue injury restoration. Once the balance
in neovascularization is disturbed, the normal physiologic
state  of  organisms  consequently  changes.  For  example,
inadequate neovascularization causes ischemia and unhealed
ulcers,  and  excessive  neovascularization  causes  tumors,
immune system diseases, and vision loss. Among the diseases
induced by unbalanced neovascularization, retina neonatal
vascular ophthalmopathy accounts for the larger proportion.
In  ophthalmocace  cases,  including  diabetic  retinopathy,
retinal vein obstruction, retinopathy of prematurity, and so on,
the occurrence of neovascularization, as well as its induced
pathologic  changes  such  as  hemorrhage,  exudation,  and
hyperplasia, can disrupt ocular structure and function, which
eventually causes severe visual impairment [1-3].
Retinal  neovascularization  occurs  in  retinal  ischemia,
hypoxia,  or  retinal  circulation  disorder.  The  new  vessel
inducer and inhibitor coregulate the formation of new vessels,
and any disturbance in their balance, such as the number of
inhibitors decreasing or the number of inducers increasing,
can lead to neovascularization [4,5].
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Vascular endothelial growth factor (VEGF), the most
important  of  the  different  regulatory  factors  in
neovascularization,  can  promote  endothelial  cell
proliferation, intravascular component leakage, extracellular
matrix change, and, ultimately, new vessel formation.
During  neovascularization,  Ras-related  C3  botulinum
toxin substrate 1 (Racl) regulates the expression and activity
of hypoxia-inducible factor-1α (HIF-1α) [6,7].The Rac1 gene
is located at 7p22 in human cells, and is widely expressed in
various tissues. The gene is a typical housekeeping gene [8].
During  neovascularization,  hypoxia  leads  to  the
phosphorylation and oxidation-reduction reaction of HIF-1α-
related  proteins.  HIF-1α  overexpression  can  increase  the
expression  of  downstream  genes  (such  as  VEGF,
erythropoietin,  glycolytic  enzyme,  etc.)  as  an  adaptive
adjustment  of  body  tissues  to  hypoxia,  which  ultimately
causes new vessel formation [9]. Rac1 can exert its inhibitory
effect on neovascularization by inhibiting HIF-1α expression
through several pathways [10,11].
Gene therapy has provided a broad research field for
treating neovascularization diseases. The methods used in
neovascularization  include  gene  replacement  therapy,
antisense RNA therapy, and so on. RNA interference (RNAi)
is a technology that uses small interfering RNA (siRNA) to
specifically  silence  homologous  gene  expression,  and  has
been  widely  used  in  treating  ocular  new  vessels,  ocular
tumors, keratonosus, lens diseases, glaucoma, etc. [12-16].
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1354Thus,  silencing  Rac1  expression  breaks  the  upstream
signaling  pathway  of  neovascularization,  effectively
inhibiting  the  formation  of  new  vessels.  Based  on  these
findings, a Rac1-siRNA vector was constructed in the present
study, and reverse transcription polymerase chain reaction
(RT–PCR) was used to investigate the inhibitory effect of
Rac1-siRNA on Rac1 expression. Animal models of retinal
neovascularization were established using the photodynamic
method, and we observed the inhibitory effect of Rac1-siRNA
on retinal neovascularization in a rat model.
METHODS
Vector construction: The complete sequence of the human
Rac1  mRNA  was  obtained  from  NCBI  (GenBank
AB029508). A total of 87 siRNA strands of human Rac1
mRNA at different loci of the coding region were designed by
the siRNA software company (Ambion, Wizard, Dharmacon,
Co. Ltd, San Antonio, TX). Three sequences were selected
according to the following requirements: (a) the sequence was
as close as possible to the designed primer region, and (b) the
sequence was homologous with that of rat Rac1 mRNA. The
homologous sequences between the selected siRNA sequence
and other gene sequences were excluded. The three siRNA
sequences were as follows: (A) 5′-AGA CGG AGC TGT
AGG TAA A-3′, (B) 5′-ATG TCC GTG CAA AGT GGT
A-3′, and (C) 5′-AAA GAC ACG ATC GAG AAA C-3′. The
siRNA oligonucleotide fragments were annealed to form the
target double-stranded DNA, followed by digestion with BglII
and Hin d III restriction enzymes and ligation into linearized
pSUPER plasmids (Oligoengine Co. Ltd., Los Angeles, CA)
digested with the same enzymes. The plasmids were then
transformed into competent E. coli DH5α and screened on
containing  plates  to  produce  the  recombinant  pSUPER–
Rac1–short hairpin RNA (shRNA) vector. The plasmids were
extracted and identified with digestion with BglII and HindIII
and  sequencing.  The  resultant  shRNA  vectors  were
designated  pSUPER–Rac1–shRNA1,  pSUPER–Rac1–
shRNA2, and pSUPER–Rac1–shRNA3.
HeLa cell transfection: HeLa cells were purchased from the
Shanghai  Cell  Bank  (Shanghai,  China).  The  cells  were
cultured  in  Dulbecco’s  modified  Eagle’s  medium
supplemented with 10% fetal calf serum at 37 °C with 5%
CO2. pSUPER–Rac1–shRNA and the pSUPER plasmid were
introduced into the HeLa cells according to the instructions
for Lipofectamine 2000 (Invitrogen, Carlsbad, CA). A day
before transfection, 0.5–2×105 cells were inoculated into six-
well  plates.  Transfection  mixtures  containing  Solution  A
(5  μg  of  plasmid  and  100  μl  of  Opti-MEM  medium,
Invitrogen,  Los  Angeles,  CA)  and  Solution  B  (10  µl  of
Lipofectamine 2000 and 100 μl of Opti-MEM medium) were
prepared in 96-well plates. After incubation for 4 h at 37 °C
and  5%  CO2,  the  transfection  medium  was  replaced  with
complete medium, and the cells were incubated for 44 h at
37 °C and 5% CO2. After transfection for 48 h, the cells were
removed from the plates, washed twice with precooled PBS
(NaCl  8.00  g/l,  KCl  0.20  g/l,  Na2HPO4•12H2O  1.56  g/l,
KH2PO4 0.20 g/l; 1,320× g, 5 min), resuspended, and adjusted
to 20×106 cells/l.
Reverse transcription polymerase chain reaction: The cells
were  collected  from  each  group,  and  the  total  RNA  was
extracted  using  TRIzol  reagent  according  to  the  kit’s
instructions  (TakaRa,  Okinawa,  Japan).  The  cells  were
reverse transcribed using the Super Script First-Strand System
RT–PCR kit (TakaRa), and the Rac1 gene was amplified with
PCR.  The  reaction  conditions  were  as  follows:  30  s  of
denaturation at 94 °C, 30 s of annealing at 55 °C, 30 s of
polymerization at 72 °C, for 35 cycles. A β-actin (ACTB)
fragment was amplified under the same conditions as the
intercontrol. The experiment was repeated three times.
Animal models and grouping: This study was performed in
strict accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institutes  of  Health.  The  animal  use  protocol  has  been
reviewed and approved by the Institutional Animal Care and
Use Committee (IACUC) of the Second People’s Hospital of
Yunnan Province, China. A total of 50 healthy and mature
Sprague-Dawley  rats  were  provided  by  the  West-China
Centre of Medical Sciences, Sichuan University. The Rac1-
shRNA  recombinant  vector  (the  interference  group)  was
transfected into the vitrea bulbi of the eyes of 25 rats, and the
blank vector (the positive control group) was transfected into
the other eye. The other 25 rats were used as the interference
negative control group. Retinal vein obstruction in the gene
interference and positive control groups was induced using
the photodynamic method. Mydriasis was induced in rats by
intraperitoneal injection of tropicamide at 15 mg to 20 mg per
kg bodyweight. After the rats were anesthetized with 1.5%
pentobarbital, tail vein puncture was performed. About 2%
rose bengal was injected into the rats at 40 mg/kg bodyweight.
Fixed under a laser ophthalmoscope mediated by 90 D preset
lenses,  all  major  retinal  veins  around  the  optic  disc  were
photocoagulated with a 532 nm laser. Within 4 DD to 1 DD
away from the optic disc, distinctive black thrombi formed in
the veins. The vein thicknesses were uneven, with tortuous
and dilated distal parts. The peripheral retinas of some rats
were interspersed with small flake-like hemorrhage. After the
models were established, Rac1-siRNA recombinant vectors
were transfected into the vitrea bulbi of the gene interference
group, blank vectors into the positive control group, and Rac1-
siRNA recombinant vectors into the negative control group.
Retinal  cell  transfection:  Rac1-siRNA  vectors  and  blank
vectors  were  mixed  with  Liposome  2000  under  sterile
conditions at a ratio of 1:1. Four rats were transfected with
recombinant and blank vectors. After routine anesthesia, a
microinjector was inserted into the back of the cornea, and 20
pmol/3 μl of the mixture was injected into each eye. Four days
after injection, the rats were sacrificed, and their eyeballs were
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1355enucleated and stored at −25 °C for 30 min. Then, 6 μm-thick
sagittal sections were cut parallel to the optic nerve. Sections
with  intact  ocular  structure  were  selected,  and  the
transfections were observed under a fluorescence microscope.
Fluorescein  isothiocyanate–dextran  retinal  angiography:
Fluorescein isothiocyanate–dextran was dissolved in sterile
SPSS to a final concentration of 50 mg/ml. After routine
anesthesia and fixation, the thoracic cavity was opened by
cutting the sternum. About 1 ml of fluorescein isothiocyanate–
dextran solution was injected into the left ventricle. Perfusion
was considered successful if the mouth, nose, and external
ears turned yellow. The eyeball was enucleated and fixed with
4%  formaldehyde.  Under  an  operation  microscope,  the
eyeball wall was cut along the limbus cornea, and the lens and
vitreous were removed. The sensory layer of the retina was
separated  from  the  pigment  epithelium  layer  with  an  iris
repository,  and  was  stretched  and  observed  under  a
fluorescence microscope.
Figure 1. Cell transfection detected by fluorescence microscope. A: The image of the frozen section of rat eyeball wall in the control group
under a microscope. Moderate green fluorescence was observed in the retinal region close to the vitrea bulbus 4 days after blank vector
transfection. B: The image under a fluorescent microscope. Green fluorescence was seen in the retinal region. C: The image of the frozen
section of rat eyeball wall in the gene interference group under a microscope. Moderate green fluorescence was seen in the retinal region close
to the vitrea bulbus 4 days after recombinant vector transfection. D: The image under a fluorescent microscope. Green fluorescence was seen
in the retinal region.
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1356Pathological observation: The rats were sacrificed, and their
eyeballs were enucleated; meanwhile, the orientations were
marked.  The  eyeballs  were  fixed  in  4%  formaldehyde
solution, routinely dehydrated, and then embedded in paraffin.
Continuous 6 µm-thick sagittal sections were made parallel to
the optic nerve. The number of endothelial cells beyond the
internal limiting membrane was counted under a microscope.
Statistical analysis: Data were analyzed using the SPSS 13.0,
Beijing,  China,  software,  and  p<0.05  was  considered
significant.
RESULTS
Rac1 expression in HeLa cells: The RT–PCR results show
that the three vectors significantly inhibited Rac1 expression
in  HeLa  cells.  The  Rac1  expression  inhibitory  rates  of
shRNA1, shRNA2, and shRNA3 were 7.05%, 9.40%, and
31.25%, respectively. The inhibitory effect of shRNA1 was
the most significant, so it was selected for use in subsequent
animal experiments.
Effect of short hairpin RNA on angiogenesis of the retina: The
selected recombinant shRNA vector and blank control vector
was transfected into the rat’s vitreous cavity successfully, and
moderate intensity fluorescence was observed (Figure 1). The
constructed  recombinant  vector  and  the  blank  vector
contained the cytomegalovirus (CMV) promoter that induced
the expression of downstream green fluorescent protein (GFP)
genes. The fluorescence proved the recombinant vector and
the blank vector effectively induced gene expression in rat
retinas.
The retina surface showed that the blank control group
produced many new blood vessels, while the shRNA group
had only fewer new blood vessels, and the blood vessels of
blank control group was normal. The vascular endothelial cell
numbers beyond the inner limiting membrane in the shRNA
interference group were more than those of blank control and
blank interference group, and showed statistical significance
(p<0.05), which suggests that Rac1-siRNA could effectively
inhibit the angiogenesis of the retina.
Retinal angiography: The retinal angiography of the positive
control group showed that the retinal vessels had abnormal
morphologies  and  distribution.  Many  abnormal  neonatal
vessel  sprouts  and  neovascularization  were  observed,  and
Figure 2. Retina preparation by fluorescein isothiocyanate-dextran heart perfusion. A: The image of rat retinal angiography in the positive
control group under a fluorescent microscope. Tortuous and thick abnormal new vessels were seen. B: The image of rat retinal angiography
in the positive control group under fluorescent microscope. Fluorescent leakage of new vessel mass was seen. C: The image of rat retinal
angiography in the gene interference group under a fluorescent microscope. Vessels were distributed in a disorganized manner. D: The image
of rat retinal angiography in the gene interference group under a fluorescent microscope. Tortuous and thick new vessels were found. E: The
image of rat retinal angiography in the gene interference group under a fluorescent microscope. Two layers of retinal vessels in normal
distribution. F: The image of rat retinal angiography in the gene interference group under a fluorescent microscope. Deep vessels were normally
arranged as a net.
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1357fluorescent  leakage  exhibited  strong  fluorescence  (Figure
2A,B).  The  shRNA  group  had  abnormal  retinal  vessel
morphology and distribution. New vessels and fluorescent
leakage  were  observed  but  without  a  large  area  of
neovascularization  (Figure  2  C,D).  The  retinal  vessel
morphology in the negative control group was normal, and
aberrant  vessels  or  fluorescent  leakage  was  not  observed
(Figure 2 E,F).
Cells beyond the inner limiting membrane: The structures of
the  retinal  sections  from  the  three  groups  were  clearly
observed. Few vascular endothelial cells beyond the inner
limiting membrane (Figure 3A) were observed, with a mean
of 1.08±0.26 in the negative control group. The number of
cells  beyond  the  inner  limiting  membrane  in  the  positive
control  group  was  higher,  with  a  mean  of  20.42  ±  2.36.
However, the cells were arranged in a disorganized manner
(Figure  3B).  The  number  of  vascular  endothelial  cells
increased,  but  only  a  few  cells  beyond  the  inner  limiting
membrane were found, with a mean of 11.14±1.10 (Figure
3C).  The  differences  among  groups  were  statistically
significant (F=47.168, p=0.000), and the differences in the
number of cells beyond the inner limiting membrane between
groups were statistically significant (F=23.768, p=0.002).
DISCUSSION
In the current study, we transfected the recombinant shRNA
vector and the blank control vector into the rat vitreous cavity
successfully,  and  moderate  intensity  fluorescence  was
observed. The retina surface showed that the blank control
group produced many new blood vessels, while the shRNA
group had only fewer new blood vessels, and the blood vessels
of blank control group were normal. The vascular endothelial
cell  numbers  beyond  the  inner  limiting  membrane  in  the
shRNA interference group were more than those of blank
Figure 3. The nucleus number beyond retinal inner limiting membrane after HE staining. A: The image of the retina in the negative control
group under a microscope. The endothelial cells were neatly arranged below the inner limiting membrane. B: The image of the retina in the
positive control group under microscope. The endothelial cells broke through the inner limiting membrane and grew in a disorganized manner.
C: The image of the retina in the short hairpin RNA group under a microscope. The number of endothelial cells increased, but only a minority
of them broke through the inner limiting membrane.
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1358control  and  the  blank  interference  group,  and  showed
statistical significance (p<0.05), which suggests that Rac1-
siRNA could effectively inhibit angiogenesis of the retina.
Some previous studies have proven that RNAi specifically
and effectively inhibits VEGF expression, and inhibits the
angiogenesis in a variety of disease models [17-20]. However,
the  application  of  RNAin  in  pertinent  ophthalmological
studies has not been reported.
In the present study, Liposome 2000 was used to mediate
Rac1-siRNA transfection into the vitrea bulbus. Liposome
mediation effectively increased the vector transfection effect,
and transfection via injection into the vitrea bulbus resulted in
localized high plasmid concentrations in the retina. Moderate
fluorescence was observed in the retina in the frozen sections,
which proved that the transfection was effective. We prepared
the  animal  models  of  retinal  neovascularization  using  the
photodynamic  method,  and  established  different  sample
groups (shRNA interference, positive control, and negative
control  groups)  to  investigate  the  inhibitory  effect  of
recombinant  vectors  on  neovascularization  and  normal
tissues. We found the retinal vessels in the shRNA group had
abnormal  structures  and  were  arranged  in  a  disorganized
manner.  New  vessels  and  fluorescence  leakage  were  also
observed, but no neovascularization was found in the positive
control  group.  Retinal  sections  were  made  to  exclude
interference from gliocytes, pericytes, and Müller cells. The
number of vascular endothelial cells in the positive control
group increased, and they were arranged in a disorganized
manner. Many cells beyond the inner limiting membrane were
found, whereas in the shRNA group, although the number of
vascular endothelial cells increased, we observed only a few
cells beyond the inner limiting membrane. The difference
between  these  groups  was  statistically  significant.
Furthermore, the results demonstrated that the Rac1-siRNA
recombinant vector had no obvious side effects on normal
retinal tissues.
In summary, Rac1-siRNA has an inhibitory effect on
multiple vascular growth factors and neovascularization in
morphology and the expression of related growth factors.
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